$0.750.75 -0.03-0.03 |(-3.52-3.52 %)
52W H: 8.169952W L: 0.4201Beta: 2.19
About Q/C Technologies Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://ir.qctechnologies.com/
Frequently Asked Questions
What is the 52-week range for QCLS?
The 52-week high is $8.1699 and the 52-week low is $0.4201.
What is the P/E ratio for QCLS?
The P/E ratio data is currently unavailable.
What is the dividend yield for QCLS?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -70.59%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -501.52%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.27.
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-04-13 | White Billy Joe | +50,000 | - | - |
| 2026-04-13 | Voss Chelsea Sierra | +50,000 | - | - |
| 2026-04-13 | Silverman Joshua | +100,000 | - | - |
| 2026-04-13 | Silverman Joshua | +162,162 | - | - |
| 2026-04-13 | Glass Mitchell | +50,000 | - | - |
| 2026-04-13 | Friscia Stephen | +50,000 | - | - |
| 2026-04-13 | Bernstein Bruce | +50,000 | - | - |
| 2026-03-30 | Voss Chelsea Sierra | +1,753 | $3.15 | $5,522 |
| 2026-01-16 | Voss Chelsea Sierra | +212,500 | - | - |
| 2026-01-16 | Voss Chelsea Sierra | +25,000 | - | - |
| 2026-01-16 | Voss Chelsea Sierra | +212,500 | - | - |
| 2025-11-14 | PharmaCyte Biotech, Inc. | +889,865 | - | - |
| 2025-11-14 | Glass Mitchell | +11,420 | - | - |
| 2025-11-14 | White Billy Joe | +22,839 | - | - |
| 2025-11-14 | Silverman Joshua | +91,356 | - | - |
| 2025-11-14 | Friscia Stephen | +22,839 | - | - |
| 2025-11-14 | Bernstein Bruce | +25,000 | - | - |
| 2025-11-14 | RAUCH GARY M | +11,420 | - | - |